Eli Lilly & Co. (LLY) Tops Q1 EPS by 21c, Raises FY EPS Guidance
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,229.93 +1.81%
EPS Growth %: +39.8%
Financial Fact:
Cost of sales, operating expenses, and other-net: 4.22B
Today's EPS Names:
DTGI, OCCI, MAYS, More
EPS Growth %: +39.8%
Financial Fact:
Cost of sales, operating expenses, and other-net: 4.22B
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q1 EPS of $1.34, $0.21 better than the analyst estimate of $1.13. Revenue for the quarter came in at $5.7 billion versus the consensus estimate of $5.49 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2018 EPS of $5.10-$5.20, versus the consensus of $4.88.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA selects seven participants for precheck pilot program to advance U.S. drug manufacturing
- American Outdoor Brands (AOUT) Tops Q4 EPS by 14c
- Methanex to idle Trinidad Titan plant after gas contract talks fail
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
